Hepatocellular Carcinoma
Conference Coverage
Fewer than 1 out of 4 patients with HCV-related liver cancer receive antivirals
This study and others suggest that these practice-altering agents are underutilized. Greater awareness of direct-acting antiviral agents is needed...
Conference Coverage
More than one-third of adults in the US could have NAFLD by 2050
Findings suggest that health care systems should prepare for “large increases” in cases of hepatocellular carcinoma (HCC) and need for liver...
From the Journals
New biomarker tests could reduce need for liver biopsy
The blood-based tests could expand diagnostic options at health care facilities and facilitate enrollment in NASH clinical trials.
Conference Coverage
Drug combo improves recurrence-free survival after HCC resection
Study shows significant improvement in recurrence-free survival with atezolizumab and bevacizumab combo.